Insight into central nervous system targeted nanostructured lipid carriers <i>via</i> the nose to brain pathway-Reference-Cited by-同舟云学术

Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway

Published:2024 Issue: Volume: Page:
ISSN:2976-8713
Container-title:RSC Pharmaceutics
language:en
Short-container-title:RSC Pharm.

Author:

Das Mridusmita¹,Sarma Anupam¹^ORCID,Baruah Himakshi¹²,Basak Debojeet¹

Affiliation:

1. Advanced Drug Delivery Laboratory, School of Pharmaceutical Sciences, Girijananda Chowdhury University, Guwahati-781017, Assam, India

2. Department of Pharmaceutics, School of Pharmacy, The Assam Kaziranga University, Jorhat, Assam

Abstract

Drug delivery to the CNS is challenging due to various physiological barriers. However, the nose-to-brain pathway offers an alternative way to deliver drugs inside the CNS using nanostructured lipid carriers for neurological diseases.

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/PM/D4PM00057A

Reference204 articles.

1. Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery

2. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting

3. Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease

4. Comparative pharmacodynamic study delineating the efficacy of amantadine loaded nano-emulsified organogel via intranasal versus transdermal route in rotenone-induced Parkinson's disease rat model

5. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies